Complications of continuous renal replacement therapy

Seminars in Dialysis

Volumn 22, Issue 2, 2009, Pages 155-159

  Finkel, Kevin W ^a,b   Podoll, Amber S ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; DISORDERS OF ACID BASE BALANCE; EMBOLISM; HUMAN; HYPOTENSION; INCIDENCE; METABOLIC DISORDER; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ACID-BASE IMBALANCE; EMBOLISM; HUMANS; HYPOTENSION; INCIDENCE; KIDNEY FAILURE, ACUTE; RENAL REPLACEMENT THERAPY; RISK FACTORS; WATER-ELECTROLYTE IMBALANCE;

EID: 65249108714     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2008.00550.x     Document Type: Article

References (56)

1. Macias WL, Mueller BA, Scarim SK, Robinson M, Rudy DW : Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 18 : 451 458, 1991
2. Mehta RL : Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin Nephrol 14 : 64 82, 1994
3. Parienti JJ, Thirion M, Megarbane B, Souweine B, Ouchikhe A, Polito A, Forel JM, Marque S, Misset B, Airapetian N, Daurel C, Mira JP, Ramakers M, du Cheyron D, Le Coutour X, Daubin C, Charbonneau P : Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA 299 : 2413 2422, 2008
4. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H : Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 54 : 154 161, 1990
5. Schillinger F, Schillinger D, Montagnac R, Milcent T : Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 6 : 722 724, 1991
6. Oliver MJ : Acute dialysis catheters. Semin Dial 14 : 432 435, 2001
7. Kelber J, Delmez JA, Windus DW : Factors affecting delivery of high-efficiency dialysis using temporary vascular access. Am J Kidney Dis 22 : 24 29, 1993
8. Canaud B : Haemodialysis catheter-related infection: time for action. Nephrol Dial Transplant 14 : 2288 2290, 1999
9. Chatzinikolaou I, Finkel K, Hanna H, Boktour M, Foringer J, Ho T, Raad I : Antibiotic-coated hemodialysis catheters for the prevention of vascular catheter-related infections: a prospective, randomized study. Am J Med 115 : 352 357, 2003
10. NF/KDOQI. NF/KDOQI clinical practice guidelines for hemodialysis adequacy: update 2000. Am J Kidney Dis 37 : S7 S64, 2001.
11. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, Masur H, McCormick RD, Mermel LA, Pearson ML, Raad II, Randolph A, Weinstein RA : Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 23 : 759 769, 2002
12. Clark WR, Mueller BA, Kraus MA, Macias WL : Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 8 : 804 812, 1997
13. Palevsky PM, Zhang JH, O'Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM, Smith MW, Swanson KM, Thompson BT, Vijayan A, Watnick S, Star RA, Peduzzi P : Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359 : 7 20, 2008
14. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G : Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356 : 26 30, 2000
15. Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM : Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol 19 : 1233 1238, 2008
16. Paganini EP, Tapolyai M, Goormastic M, Halstenberg W, Kozlowski L, Leblanc M, Lee JC, Moreno L, Sakai K : Establishing a dialysis therapypatient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 28 (Suppl 3 S81 S89, 1996
17. Tardy B, Lecompte T, Boelhen F, Tardy-Poncet B, Elalamy I, Morange P, Gruel Y, Wolf M, Francois D, Racadot E, Camarasa P, Blouch MT, Nguyen F, Doubine S, Dutrillaux F, Alhenc-Gelas M, Martin-Toutain I, Bauters A, Ffrench P, de Maistre E, Grunebaum L, Mouton C, Huisse MG, Gouault-Heilmann M, Lucke V : Predictive factors for thrombosis and major bleeding in an observational study in 181 patients with heparin-induced thrombocytopenia treated with lepirudin. Blood 108 : 1492 1496, 2006
18. Gutierrez A, Alvestrand A, Wahren J, Bergstrom J : Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 38 : 487 494, 1990
19. Brunet P, Jaber K, Berland Y, Baz M : Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors. Am J Kidney Dis 19 : 444 447, 1992
20. Perez-Garcia R, Galan A, Garcia Vinuesa M, Anaya F, Valderrabano F : Anaphylactoid reactions during hemodialysis on AN69 membranes: role of ACE inhibitors and back-filtration. Nephron 61 : 123, 1992
21. Finkel KW, Foringer JR : Safety of regional citrate anticoagulation for continuous sustained low efficiency dialysis (C-SLED) in critically ill patients. Ren Fail 27 : 541 545, 2005
22. Mehta RL, McDonald BR, Aguilar MM, Ward DM : Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38 : 976 981, 1990
23. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG : Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 60 : 370 374, 2001
24. Mitchell A, Daul AE, Beiderlinden M, Schafers RF, Heemann U, Kribben A, Peters J, Philipp T, Wenzel RR : A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD). Clin Nephrol 59 : 106 114, 2003
25. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P : Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30 : 260 265, 2004
26. Bihorac A, Ross EA : Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition. Am J Kidney Dis 46 : 908 918, 2005
27. Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C : Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 28 : 1419 1425, 2002
28. Meier-Kriesche HU, Finkel KW, Gitomer JJ, DuBose TD Jr. : Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 33 : e8, 1999
29. Meier-Kriesche HU, Gitomer J, Finkel K, DuBose T : Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 29 : 748 752, 2001
30. Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkoff-Rubin N : Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 304 : 934 939, 1981
31. Kaplan AA, Petrillo R : Regional heparinization for continuous arterio-venous hemofiltration (CAVH). ASAIO Trans 33 : 312 315, 1987
32. van der Voort PH, Gerritsen RT, Kuiper MA, Egbers PH, Kingma WP, Boerma EC : Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation. Blood Purif 23 : 175 180, 2005
33. Warkentin TE, Cook DJ : Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU. Crit Care Clin 21 : 513 529, 2005
34. Lasocki S, Piednoir P, Ajzenberg N, Geffroy A, Benbara A, Montravers P : Anti-PF4heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study. Crit Care 12 : R84, 2008
35. Boldt J, Menges T, Wollbruck M, Sonneborn S, Hempelmann G : Continuous hemofiltration and platelet function in critically ill patients. Crit Care Med 22 : 1155 1160, 1994
36. Salmon J, Cardigan R, Mackie I, Cohen SL, Machin S, Singer M : Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways. Intensive Care Med 23 : 38 43, 1997
37. Noon GP, Kane LE, Feldman L, Peterson JA, DeBakey ME : Reduction of blood trauma in roller pumps for long-term perfusion. World J Surg 9 : 65 71, 1985
38. Locatelli F, Pontoriero G, Di Filippo S : Electrolyte disorders and substitution fluid in continuous renal replacement therapy. Kidney Int Suppl 66 : S151 S155, 1998
39. Morimatsu H, Uchino S, Bellomo R, Ronco C : Continuous renal replacement therapy: does technique influence electrolyte and bicarbonate control? Int J Artif Organs 26 : 289 296, 2003
40. Barenbrock M, Hausberg M, Matzkies F, de la Motte S, Schaefer RM : Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int 58 : 1751 1757, 2000
41. Druml W : Protein metabolism in acute renal failure. Miner Electrolyte Metab 24 : 47 54, 1998
42. Hynote ED, McCamish MA, Depner TA, Davis PA : Amino acid losses during hemodialysis: effects of high-solute flux and parenteral nutrition in acute renal failure. JPEN J Parenter Enteral Nutr 19 : 15 21, 1995
43. Mokrzycki MH, Kaplan AA : Protein losses in continuous renal replacement therapies. J Am Soc Nephrol 7 : 2259 2263, 1996
44. Wooley JA, Btaiche IF, Good KL : Metabolic and nutritional aspects of acute renal failure in critically ill patients requiring continuous renal replacement therapy. Nutr Clin Pract 20 : 176 191, 2005
45. Scheinkestel CD, Adams F, Mahony L, Bailey M, Davies AR, Nyulasi I, Tuxen DV : Impact of increasing parenteral protein loads on amino acid levels and balance in critically ill anuric patients on continuous renal replacement therapy. Nutrition 19 : 733 740, 2003
46. Grootendorst AF, van Bommel EF, van der Hoven B, van Leengoed LA, van Osta AL : High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig. Intensive Care Med 18 : 235 240, 1992
47. Obialo CI, Okonofua EC, Nzerue MC, Tayade AS, Riley LJ : Role of hypoalbuminemia and hypocholesterolemia as copredictors of mortality in acute renal failure. Kidney Int 56 : 1058 1063, 1999
48. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R : Intensive insulin therapy in the critically ill patients. N Engl J Med 345 : 1359 1367, 2001
49. Basi S, Pupim LB, Simmons EM, Sezer MT, Shyr Y, Freedman S, Chertow GM, Mehta RL, Paganini E, Himmelfarb J, Ikizler TA : Insulin resistance in critically ill patients with acute renal failure. Am J Physiol Renal Physiol 289 : F259 F264, 2005
50. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R : Intensive insulin therapy in the medical ICU. N Engl J Med 354 : 449 461, 2006
51. Bollmann MD, Revelly JP, Tappy L, Berger MM, Schaller MD, Cayeux MC, Martinez A, Chiolero RL : Effect of bicarbonate and -lactate buffer on glucose and lactate metabolism during hemodiafiltration in patients with multiple organ failure. Intensive Care Med 30 : 1103 1110, 2004
52. Berger MM, Shenkin A : Update on clinical micronutrient supplementation studies in the critically ill. Curr Opin Clin Nutr Metab Care 9 : 711 716, 2006
53. Berger MM, Shenkin A, Revelly JP, Roberts E, Cayeux MC, Baines M, Chiolero RL : Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 80 : 410 416, 2004
54. Baldwin IC : Training, management, and credentialing for CRRT in the ICU. Am J Kidney Dis 30 : S112 S116, 1997
55. Golper TA, Marx MA : Drug dosing adjustments during continuous renal replacement therapies. Kidney Int Suppl 66 : S165 S168, 1998
56. Conger J : Does hemodialyis delay recovery from acute renal failure. Semin Dial 3 : 146 148, 1990